Company: BDRX
Filing Date: 2025-07-18
Form Type: 424B3
Source: 0001214659-25-010633
Chunk: 3

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-07-18
Form: 424B3
Chunk 3
---
 fact should be considered forward-looking statements.

Reference should be made to those documents that
Biodexa shall file from time to time or announcements that may be made by Biodexa in accordance with the rules and regulations promulgated
by the SEC, which contain and identify other important factors that could cause actual results to differ materially from those contained
in any projections or forward-looking statements. These forward-looking statements speak only as of the date of this announcement.
All subsequent written and oral forward-looking statements by or concerning Biodexa are expressly qualified in their entirety by the cautionary
statements above. Except as may be required under relevant laws in the United States, Biodexa does not undertake any obligation
to publicly update or revise any forward-looking statements because of new information, future events or events otherwise arising.